David Windley
Stock Analyst at Jefferies
(3.62)
# 790
Out of 4,876 analysts
191
Total ratings
66.97%
Success rate
13.42%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STE STERIS | Initiates: Hold | $263 | $238.79 | +10.14% | 1 | May 29, 2025 | |
| SLQT SelectQuote | Initiates: Hold | $2.75 | $2.30 | +19.57% | 1 | May 21, 2025 | |
| CNC Centene | Maintains: Hold | $64 → $61 | $53.99 | +12.98% | 28 | Apr 29, 2025 | |
| OSCR Oscar Health | Initiates: Underperform | $12 | $20.41 | -41.21% | 1 | Dec 10, 2024 | |
| HUM Humana | Downgrades: Hold | $419 → $253 | $241.88 | +4.60% | 18 | Oct 7, 2024 | |
| FTRE Fortrea Holdings | Downgrades: Hold | $25 → $21 | $4.98 | +321.69% | 2 | Sep 25, 2024 | |
| MEDP Medpace Holdings | Downgrades: Hold | $415 → $345 | $310.69 | +11.04% | 5 | Sep 25, 2024 | |
| CI The Cigna Group | Maintains: Buy | $402 → $422 | $326.31 | +29.32% | 17 | Sep 17, 2024 | |
| MOH Molina Healthcare | Maintains: Hold | $354 → $297 | $297.05 | -0.02% | 23 | Jul 24, 2024 | |
| IQV IQVIA Holdings | Downgrades: Hold | $266 → $242 | $157.47 | +53.68% | 4 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $481 → $647 | $309.11 | +109.31% | 26 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $12 → $3.75 | $1.70 | +120.59% | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $602 → $604 | $381.49 | +58.33% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $365 → $375 | $533.71 | -29.74% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $16 | $11.32 | +36.93% | 3 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $270 | $283.41 | -4.73% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $16 | $11.38 | +36.20% | 3 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $323 → $536 | $218.87 | +144.89% | 10 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $39 → $29 | $24.64 | +17.69% | 2 | Nov 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $233 → $203 | $150.01 | +35.32% | 19 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $276 → $302 | $144.56 | +108.91% | 14 | Sep 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $264 → $248 | $8.41 | +2,848.87% | 1 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.49 | - | 5 | Oct 9, 2017 |
STERIS
May 29, 2025
Initiates: Hold
Price Target: $263
Current: $238.79
Upside: +10.14%
SelectQuote
May 21, 2025
Initiates: Hold
Price Target: $2.75
Current: $2.30
Upside: +19.57%
Centene
Apr 29, 2025
Maintains: Hold
Price Target: $64 → $61
Current: $53.99
Upside: +12.98%
Oscar Health
Dec 10, 2024
Initiates: Underperform
Price Target: $12
Current: $20.41
Upside: -41.21%
Humana
Oct 7, 2024
Downgrades: Hold
Price Target: $419 → $253
Current: $241.88
Upside: +4.60%
Fortrea Holdings
Sep 25, 2024
Downgrades: Hold
Price Target: $25 → $21
Current: $4.98
Upside: +321.69%
Medpace Holdings
Sep 25, 2024
Downgrades: Hold
Price Target: $415 → $345
Current: $310.69
Upside: +11.04%
The Cigna Group
Sep 17, 2024
Maintains: Buy
Price Target: $402 → $422
Current: $326.31
Upside: +29.32%
Molina Healthcare
Jul 24, 2024
Maintains: Hold
Price Target: $354 → $297
Current: $297.05
Upside: -0.02%
IQVIA Holdings
Jul 24, 2024
Downgrades: Hold
Price Target: $266 → $242
Current: $157.47
Upside: +53.68%
Jul 17, 2024
Upgrades: Buy
Price Target: $481 → $647
Current: $309.11
Upside: +109.31%
May 14, 2024
Downgrades: Hold
Price Target: $12 → $3.75
Current: $1.70
Upside: +120.59%
Apr 19, 2024
Maintains: Buy
Price Target: $602 → $604
Current: $381.49
Upside: +58.33%
Apr 19, 2024
Maintains: Hold
Price Target: $365 → $375
Current: $533.71
Upside: -29.74%
Mar 25, 2024
Upgrades: Buy
Price Target: $15 → $16
Current: $11.32
Upside: +36.93%
Mar 4, 2024
Maintains: Buy
Price Target: $225 → $270
Current: $283.41
Upside: -4.73%
Mar 1, 2024
Maintains: Hold
Price Target: $14 → $16
Current: $11.38
Upside: +36.20%
Feb 7, 2024
Upgrades: Buy
Price Target: $323 → $536
Current: $218.87
Upside: +144.89%
Nov 1, 2023
Downgrades: Hold
Price Target: $39 → $29
Current: $24.64
Upside: +17.69%
Mar 28, 2023
Maintains: Hold
Price Target: $233 → $203
Current: $150.01
Upside: +35.32%
Sep 14, 2021
Maintains: Buy
Price Target: $276 → $302
Current: $144.56
Upside: +108.91%
Feb 25, 2021
Maintains: Hold
Price Target: $264 → $248
Current: $8.41
Upside: +2,848.87%
Oct 9, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.49
Upside: -